HealthStream (NASDAQ:HSTM) Share Price Breaks Above 200 Day Moving Average – Should You Sell?

HealthStream, Inc. (NASDAQ:HSTM)’s stock price crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $25.61 and traded as high as $29.76. HealthStream shares last traded at $29.74, with a volume of 153,663 shares traded.

Wall Street Analysts Forecast Growth

HSTM has been the topic of several recent analyst reports. Weiss Ratings raised HealthStream from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, August 28th. Wall Street Zen upgraded shares of HealthStream from a “hold” rating to a “buy” rating in a research report on Sunday, August 30th. Finally, Canaccord Genuity Group boosted their target price on shares of HealthStream from $24.00 to $27.00 and gave the stock a “hold” rating in a report on Tuesday, July 21st. Three investment analysts have rated the stock with a Hold rating, According to MarketBeat, HealthStream currently has a consensus rating of “Hold” and a consensus target price of $27.00.

HealthStream Price Performance

The business has a 50-day moving average of $28.86 and a 200 day moving average of $25.68. The company has a market capitalization of $887.12 million, a PE ratio of 42.17, a P/E/G ratio of 3.44 and a beta of 0.44.

HealthStream (NASDAQ:HSTM) last released its quarterly earnings results on Monday, August 3rd. The technology company reported $0.23 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.06. The business had revenue of $83.73 million during the quarter, compared to analysts’ expectations of $80.82 million. HealthStream had a return on equity of 6.81% and a net margin of 6.60%. As a group, research analysts anticipate that HealthStream, Inc. will post 0.72 EPS for the current year.

HealthStream Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, August 28th. Shareholders of record on Monday, August 17th were given a dividend of $0.0350 per share. The ex-dividend date was Monday, August 17th. This represents a $0.14 annualized dividend and a yield of 0.5%. HealthStream’s dividend payout ratio (DPR) is 19.44%.

Insiders Place Their Bets

In related news, Director Linda Rebrovick sold 6,000 shares of the stock in a transaction dated Monday, July 6th. The shares were sold at an average price of $29.00, for a total value of $174,000.00. Following the completion of the transaction, the director owned 51,329 shares of the company’s stock, valued at approximately $1,488,541. This trade represents a 10.47% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Robert A. Frist, Jr. sold 144,068 shares of the stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $29.50, for a total transaction of $4,250,006.00. Following the completion of the transaction, the chief executive officer directly owned 3,907,038 shares of the company’s stock, valued at approximately $115,257,621. The trade was a 3.56% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 20.40% of the company’s stock.

Institutional Investors Weigh In On HealthStream

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in HSTM. Arrowstreet Capital Limited Partnership lifted its position in HealthStream by 21.1% in the first quarter. Arrowstreet Capital Limited Partnership now owns 377,945 shares of the technology company’s stock worth $7,827,000 after buying an additional 65,806 shares during the last quarter. Quantinno Capital Management LP increased its position in HealthStream by 283.5% during the first quarter. Quantinno Capital Management LP now owns 50,169 shares of the technology company’s stock valued at $1,039,000 after acquiring an additional 37,088 shares during the last quarter. Lazard Asset Management LLC raised its stake in shares of HealthStream by 268.2% in the first quarter. Lazard Asset Management LLC now owns 157,208 shares of the technology company’s stock valued at $3,256,000 after acquiring an additional 114,511 shares during the period. Dimensional Fund Advisors LP raised its stake in shares of HealthStream by 6.4% in the first quarter. Dimensional Fund Advisors LP now owns 1,456,043 shares of the technology company’s stock valued at $30,156,000 after acquiring an additional 87,177 shares during the period. Finally, Bank of New York Mellon Corp bought a new stake in shares of HealthStream in the 2nd quarter worth about $6,199,000. 69.58% of the stock is currently owned by hedge funds and other institutional investors.

HealthStream Company Profile

HealthStream, Inc provides workforce and provider solutions designed for healthcare organizations. Its cloud-based offerings help hospitals, health systems and other healthcare providers manage employee training, education, credentialing, compliance and professional development.

The company’s products and services include learning and talent-management tools, provider credentialing and enrollment solutions, performance assessment, clinical development resources, and patient-experience measurement services.